ATE170754T1 - Eine caseinfraktion zur therapeutischen vorbeugenden und/oder diagnostischen verwendung bei atemweginfektionen - Google Patents

Eine caseinfraktion zur therapeutischen vorbeugenden und/oder diagnostischen verwendung bei atemweginfektionen

Info

Publication number
ATE170754T1
ATE170754T1 AT90916537T AT90916537T ATE170754T1 AT E170754 T1 ATE170754 T1 AT E170754T1 AT 90916537 T AT90916537 T AT 90916537T AT 90916537 T AT90916537 T AT 90916537T AT E170754 T1 ATE170754 T1 AT E170754T1
Authority
AT
Austria
Prior art keywords
therapeutic
preventional
casin
fraction
diagnostic use
Prior art date
Application number
AT90916537T
Other languages
English (en)
Inventor
Bengt Andersson
Gustaf Aniansson
Ragnar Lindstedt
Eden Catharina Svanborg
Original Assignee
Bengt Andersson
Gustaf Aniansson
Ragnar Lindstedt
Eden Catharina Svanborg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bengt Andersson, Gustaf Aniansson, Ragnar Lindstedt, Eden Catharina Svanborg filed Critical Bengt Andersson
Application granted granted Critical
Publication of ATE170754T1 publication Critical patent/ATE170754T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/202—Casein or caseinates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Polymers & Plastics (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT90916537T 1989-10-30 1990-10-30 Eine caseinfraktion zur therapeutischen vorbeugenden und/oder diagnostischen verwendung bei atemweginfektionen ATE170754T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8903625A SE465109B (sv) 1989-10-30 1989-10-30 Antibakteriell komposition

Publications (1)

Publication Number Publication Date
ATE170754T1 true ATE170754T1 (de) 1998-09-15

Family

ID=20377332

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90916537T ATE170754T1 (de) 1989-10-30 1990-10-30 Eine caseinfraktion zur therapeutischen vorbeugenden und/oder diagnostischen verwendung bei atemweginfektionen

Country Status (15)

Country Link
EP (1) EP0454813B1 (de)
JP (1) JPH04503077A (de)
KR (1) KR920700678A (de)
AT (1) ATE170754T1 (de)
AU (1) AU633647B2 (de)
CA (1) CA2044244A1 (de)
DE (1) DE69032646T2 (de)
DK (1) DK0454813T3 (de)
ES (1) ES2121755T3 (de)
FI (1) FI102516B (de)
HU (1) HU212935B (de)
NO (1) NO912391D0 (de)
RU (1) RU2035913C1 (de)
SE (1) SE465109B (de)
WO (1) WO1991006308A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538952A (en) * 1994-05-26 1996-07-23 Abbott Laboratories Inhibition of infection of mammalian cells by respiratory syncytial virus
CA2190609A1 (en) * 1994-05-26 1995-12-07 Pradip Mukerji Inhibition of infection of mammalian cells by respiratory syncytial virus
US5506209A (en) * 1994-05-26 1996-04-09 Abbott Laboratories Product for inhibition of infection of mammalian cells by respiratory syncytial virus
US5707968A (en) * 1994-05-26 1998-01-13 Abbott Laboratories Inhibition of attachment of H.influenzae to human cells
WO1995032728A1 (en) * 1994-05-26 1995-12-07 Abbott Laboratories Inhibition of attachment of h. influenzae to human cells
US5643880A (en) * 1994-05-26 1997-07-01 Abbott Laboratories Product for inhibition of attachment of H. influenzae to human cells
US5942254A (en) * 1995-02-27 1999-08-24 Abbott Laboratories Phosphorylated recombinant human β-casein expressed in a bacterial system
JP2000500141A (ja) * 1995-11-06 2000-01-11 アボツト・ラボラトリーズ リン酸化された組換えヒトベータ−カゼインを用いるヒト細胞に対するインフルエンザ菌の付着阻止方法
AU1158197A (en) * 1995-11-06 1997-08-11 Abbott Laboratories Product for inhibition of attachment of h. influenzae to human cells
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
BR0215954A (pt) 2002-11-26 2005-09-13 Uc Tech Métodos de redução da possibilidade de mortalidade em um animal, de expressão virulenta em um patógeno intestinal, e da expressão de adesina / lectina pa-i em uma célula bacteriana, de inibição de expressão de adesina / lectina pa-i em um patógeno intestinal, de ativação induzida por intestino de adesina / lectina pa-i, de mudança morfológica induzida por c4-hsl de um patógeno intestinal, e de aderência de célula bacteriana em um intestino de mamìfero, de melhoria de patogênese intestinal, de prevenção de uma doença ou condição anormal, de infecção de pele e respiratória, de uma doença sexualmente transmitida, de um distúrbio de trato digestivo, de perda de capacidade lactante em um animal, e de desenvolvimento de um distúrbio epitelial mediado por micróbio em uma animal de idade de amamentação, de irrigação de pelo menos uma porção do trato urinário, e para monitoração da administração de poli (etileno-glicol) (peg) a um animal, composição farmacêutica, kits para a prevenção ou tratamento terapêutico de sepsia derivada de intestino, e para a monitoração da administração de poli (etileno-glicol), e, preservativo
RU2346694C2 (ru) * 2002-11-26 2009-02-20 Дзе Юниверсити Оф Чикаго Вещества и способы для профилактики и лечения опосредованных микроорганизмами эпителиальных нарушений
US20110059062A1 (en) * 2007-07-06 2011-03-10 Michael A Pellico Use of hydrolytic and oxidative enzymes to dissolve biofilm in airway passages

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1496671A (en) * 1975-03-27 1977-12-30 Grindstedvaerket As Anti-cancer-active sour milk fraction
FR2491334A1 (fr) * 1980-10-03 1982-04-09 Inst Nat Sante Rech Med Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant
FR2592769B1 (fr) * 1986-01-10 1990-10-12 Agronomique Inst Nat Rech Procede d'obtention d'une matiere enrichie en caseine beta, appareillage pour la mise en oeuvre de ce procede, et application des produits obtenus par ce procede comme aliments, complements alimentaires ou additifs en industrie alimentaire et pharmaceutique ou dans la preparation de peptides a activite physiologique
JP2631470B2 (ja) * 1987-05-15 1997-07-16 雪印乳業株式会社 感染防御剤

Also Published As

Publication number Publication date
DE69032646T2 (de) 1999-05-27
WO1991006308A1 (en) 1991-05-16
EP0454813A1 (de) 1991-11-06
SE8903625D0 (sv) 1989-10-30
NO912391L (no) 1991-06-19
SE465109B (sv) 1991-07-29
FI913154A0 (fi) 1991-06-28
NO912391D0 (no) 1991-06-19
DE69032646D1 (de) 1998-10-15
DK0454813T3 (da) 1999-02-01
CA2044244A1 (en) 1991-05-01
EP0454813B1 (de) 1998-09-09
KR920700678A (ko) 1992-08-10
FI102516B1 (fi) 1998-12-31
FI102516B (fi) 1998-12-31
JPH04503077A (ja) 1992-06-04
AU6647090A (en) 1991-05-31
RU2035913C1 (ru) 1995-05-27
HU212935B (en) 1996-12-30
AU633647B2 (en) 1993-02-04
SE8903625L (sv) 1991-05-01
ES2121755T3 (es) 1998-12-16

Similar Documents

Publication Publication Date Title
ATE170754T1 (de) Eine caseinfraktion zur therapeutischen vorbeugenden und/oder diagnostischen verwendung bei atemweginfektionen
EP0909814A3 (de) Verwendung von Proteinkinasen zur Diagnose und Behandlung der Alzheimer'schen Krankheit
MXPA03000103A (es) Antigenos de streptococcus.
ATE329031T1 (de) Therapeutische zusammensetzungen zur behandlung von lawsonia intracellularis infektionen
AP2000001886A0 (en) Group B streptococcus antigens.
ATE165395T1 (de) Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
WO2002046222A3 (en) Compositions and methods for diagnosing alzheimer's disease
DE69419782D1 (de) Multimeres alpha-lactalbumin enthaltende antibakterielle zusammensetzung
WO2002046221A3 (en) Human protein differentially expressed in alzheimer's disease's brain
WO1992021697A3 (en) Diagnostic peptides derived from m.tuberculosis antigens
Crook et al. Age associated memory impairment
ATE453627T1 (de) Herstellung von verbindungen zur bestimmung der hypoxie
DE69835519D1 (de) Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind.
ATE208420T1 (de) Protein des cadherin-typs aus knochen und verfahren zur herstellung
Yoo et al. Experimental salivary pellicles formed on the surface of self‐curing resin
DE69224795D1 (de) 4Verfahren und Zusammensetzungen zur Vorbeugung, Diagnose und Behandlung seröser Entzündungen und damit verbundener Störungen
DE60018919D1 (de) Verwendung von milchsaürebakterien bei der herstellung von fermentierten milchprodukten zur behandlung von verringerten immunitätsebenen
Walker Calcification in the South African Bantu
Wolfe et al. Thrombosis and pulmonary embolism: Authors' reply
Robinson Thrombosis and pulmonary embolism
Raeburn Antibiotic levels in tissue fluid
Carter Huffman v. Lindquist [DISSENT]
Wolf Natrum carb. vs Natrum sulph.
Garcia-Webb et al. Serum lithium estimations
Stern et al. Serum Lithium Estimations SIR,-We read with some amazement the

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties